Journal Editorial - Translating HARMS2-AF into benefits for our atrial fibrillation patients and the general public: challenges and opportunities
ESC Cardio Talk
00:00
Discussing the Limitations of the Study
Discussion of the limitations and strengths of the study being analyzed, including the reliance on self-report for lifestyle factors and the issue with outcome ascertainment in the UK biobank.
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
